Avantor, Inc. (AVTR)

Avantor stock has had a difficult run, with longer term shareholders still well underwater. However, the current market price sits at a discount to an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach, and the broader valuation checks also lean toward the shares looking ...

Avantor (AVTR) is back in focus after several hedge funds increased their holdings, just weeks before the company reports its second quarter 2026 earnings and hosts an investor call on July 29. See our latest analysis for Avantor. The recent hedge fund activity comes as Avantor’s share price has pic…

We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AVTR.

Shares of life sciences company Avantor (NYSE:AVTR) jumped 3.2% in the morning session after an analyst at Barclays boosted their price target on the stock and the company formally concluded its CFO transition on June 24, removing a governance concern.

In recent months, several institutional investors, including Ed Wachenheim’s Greenhaven Associates, have increased or initiated positions in Avantor, with Greenhaven adding more than 2 million shares during the quarter. This renewed institutional interest highlights how value-focused investors ...